Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Brain Infarction
- Normal Saline Infusion for Stroke After Intravenous Thrombolysis
- Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)
- Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study
- Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
- For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
- Efficacy of Clopidogrel on Incidence of Silent Brain Infarction
- Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis
- Fluoxetine Opens Window to Improve Motor Recovery After Stroke
- Antiplatelet Therapy for Silent Brain Infarction
- The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
- Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
- ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
- Aortic Arch Related Cerebral Hazard Trial (ARCH)
- Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
- Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline